Rocket Pharmaceuticals Inc (NASDAQ: RCKT) flaunted slowness of -3.80% at $6.59, as the Stock market unbolted on Wednesday, before settling in for the price of $6.85 at the close. Taking a more long-term approach, RCKT posted a 52-week range of $4.55-$26.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -11.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 14.65%. This publicly-traded company’s shares outstanding now amounts to $106.75 million, simultaneously with a float of $99.76 million. The organization now has a market capitalization sitting at $709.99 million. At the time of writing, stock’s 50-day Moving Average stood at $7.00, while the 200-day Moving Average is $12.78.
Rocket Pharmaceuticals Inc (RCKT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Rocket Pharmaceuticals Inc industry. Rocket Pharmaceuticals Inc’s current insider ownership accounts for 7.41%, in contrast to 93.42% institutional ownership. According to the most recent insider trade that took place on May 16 ’25, this organization’s insider sold 655 shares at the rate of 6.53, making the entire transaction reach 4,276 in total value, affecting insider ownership by 64,384. Preceding that transaction, on May 16 ’25, Company’s insider sold 1,409 for 6.53, making the whole transaction’s value amount to 9,198. This particular insider is now the holder of 442,694 in total.
Rocket Pharmaceuticals Inc (RCKT) Earnings and Revenue Records
Rocket Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 14.65% and is forecasted to reach -1.60 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 43.25% through the next 5 years, which can be compared against the -11.60% growth it accomplished over the previous five years trading on the market.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Let’s observe the current performance indicators for Rocket Pharmaceuticals Inc (RCKT). It’s Quick Ratio in the last reported quarter now stands at 9.19. The Stock has managed to achieve an average true range (ATR) of 0.65.
In the same vein, RCKT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.63, a figure that is expected to reach -0.58 in the next quarter, and analysts are predicting that it will be -1.60 at the market close of one year from today.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Now, what If we examine the latest scores posted by [Rocket Pharmaceuticals Inc, RCKT]. During the last 5-days, its volume was better the volume of 2.35 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 54.49% While, its Average True Range was 0.65.
Raw Stochastic average of Rocket Pharmaceuticals Inc (RCKT) in the period of the previous 100 days is set at 23.18%, which indicates a major fall in contrast to 34.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 120.27% that was higher than 88.13% volatility it exhibited in the past 100-days period.
